Abstract |
Kleine-Levin syndrome (KLS) is a rare sleep disorder, predominantly affecting adolescent males, which presents as recurrent episodes of hypersomnia, behavioral and cognitive disturbances, hyperphagia and sometimes hypersexuality (Lisk, " Kleine-Levin syndrome." Pract Neurol 2009;9:42-45). Modafinil has been reported to show an effect in shortening the duration of symptomatic periods, but does not affect the recurrence rate (Huang et al., " Kleine-Levin syndrome: current status." Med Clin N Am 2010;94:557-562). However, no single drug therapy has been consistently successful, despite various psychotropic agents, including lithium, anticonvulsants and antidepressants, having been systematically tried (Arnulf et al., " Kleine-Levin syndrome: a systematic study of 108 patients." Ann Neurol 2008;63:482-492). This study reports a male adolescent with KLS who received several courses of drug therapy, providing a chance to compare differential drug effects over time.
|
Authors | Chi-Chun Yao, Ying Lin, Hui-Ching Liu, Chau-Shoun Lee |
Journal | General hospital psychiatry
(Gen Hosp Psychiatry)
2013 Jan-Feb
Vol. 35
Issue 1
Pg. 102.e7-9
ISSN: 1873-7714 [Electronic] United States |
PMID | 22520717
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Adrenal Cortex Hormones
- Anticonvulsants
- Antimanic Agents
- Lithium Compounds
- Carbamazepine
- Valproic Acid
- Lorazepam
- Oxcarbazepine
|
Topics |
- Adolescent
- Adrenal Cortex Hormones
(therapeutic use)
- Anticonvulsants
(therapeutic use)
- Antimanic Agents
(therapeutic use)
- Carbamazepine
(analogs & derivatives, therapeutic use)
- Cerebral Cortex
(physiopathology)
- Electroencephalography
- Humans
- Kleine-Levin Syndrome
(drug therapy, physiopathology)
- Lithium Compounds
(therapeutic use)
- Lorazepam
(therapeutic use)
- Male
- Oxcarbazepine
- Pulse Therapy, Drug
- Valproic Acid
(therapeutic use)
|